Related references
Note: Only part of the references are listed.After Analysis, Bluebird Bio Says Vector Very Unlikely Cause of Acute Myeloid Leukemia
Alex Philippidis
HUMAN GENE THERAPY (2021)
A pause in gene therapy: Reflecting on the unique challenges of sickle cell disease
Alexis Leonard et al.
MOLECULAR THERAPY (2021)
Are genetic approaches still needed to cure sickle cell disease?
Robert A. Brodsky et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease
Matthew M. Hsieh et al.
BLOOD ADVANCES (2020)
DNMT3A clonal Hematopoiesis in Older Donors Is Associated with Improved Survival in Recipients after Allogeneic Hematopoietic Cell Transplant
Christopher J. Gibson et al.
BLOOD (2020)
Effect of increased dose of total body irradiation on graft failure associated with HLA-haploidentical transplantation in patients with severe haemoglobinopathies: a prospective clinical trial
Javier Bolanos-Meade et al.
LANCET HAEMATOLOGY (2019)
Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Learning Collaborative
Josu de la Fuente et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Decreased median survival of adults with sickle cell disease after adjusting for left truncation bias: a pooled analysis
Michael R. DeBaun et al.
BLOOD (2019)
A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease
Liuhong Cai et al.
STEM CELLS TRANSLATIONAL MEDICINE (2018)
Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma
Tomas Radivoyevitch et al.
LEUKEMIA RESEARCH (2018)
Sickle cell disease
Gregory J. Kato et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Should an HLA-matched donor still be considered the perfect donor?
Richard J. Jones et al.
LANCET HAEMATOLOGY (2018)
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma
Christopher J. Gibson et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Gene Therapy in a Patient with Sickle Cell Disease
Jean-Antoine Ribeil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Increased risk of leukemia among sickle cell disease patients in California
Ann Brunson et al.
BLOOD (2017)
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes
Catherine C. Coombs et al.
CELL STEM CELL (2017)
Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly
Florian Zink et al.
BLOOD (2017)
Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life
Rocio Acuna-Hidalgo et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
Donor-engrafted CHIP is common among stem cell transplant recipients with unexplained cytopenias
Christopher J. Gibson et al.
BLOOD (2017)
Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years
Shruti Chaturvedi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Risk of individual malignant neoplasms in patients with sickle cell disease: English national record linkage study
Olena O. Seminog et al.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2016)
Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation
L. P. Gondek et al.
LEUKEMIA (2016)
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
David P. Steensma et al.
BLOOD (2015)
The trials and hopes for drug development in sickle cell disease
Kenneth I. Ataga et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Survival Among Children and Adults With Sickle Cell Disease in Belgium: Benefit From Hydroxyurea Treatment
Phu Quoc Le et al.
PEDIATRIC BLOOD & CANCER (2015)
Hydroxycarbamide treatment in sickle cell disease: estimates of possible leukaemia risk and of hospitalization survival benefit
Oswaldo Castro et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Leukemic evolution of donor-derived cells harboring IDH2 and DNMT3A mutations after allogeneic stem cell transplantation
T. Yasuda et al.
LEUKEMIA (2014)
Donor Cell Leukemia: A Review
Daniel H. Wiseman
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease.
Matthew M. Hsieh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London
Paul Telfer et al.
HAEMATOLOGICA (2007)
Share Paper
